148 related articles for article (PubMed ID: 33086767)
1. A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies.
Schaerer D; Froehlich TK; Hamzic S; Offer SM; Diasio RB; Joerger M; Amstutz U; Largiadèr CR
J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33086767
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer.
Marsh S; McKay JA; Cassidy J; McLeod HL
Int J Oncol; 2001 Aug; 19(2):383-6. PubMed ID: 11445856
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase pharmacogenetics in colorectal cancer.
Marsh S; McLeod HL
Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe.
Pastorakova A; Chandogova D; Chandoga J; Luha J; Bohmer D; Malova J; Braxatorisova T; Juhosova M; Reznakova S; Petrovic R
Neoplasma; 2017; 64(6):962-970. PubMed ID: 28895423
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the tandem repeats in thymidylate synthase enhancer region (TSER) in primates.
Zhang YW; Luo HR; Ryder OA; Zhang YP
Gene; 2004 Aug; 338(1):47-54. PubMed ID: 15302405
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase pharmacogenetics.
Marsh S
Invest New Drugs; 2005 Dec; 23(6):533-7. PubMed ID: 16267625
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the TSER and G>C variants in the
Favela-Mendoza AF; Godínez-López AD; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortes G; Rangel-Villalobos H
Ann Hum Biol; 2023 Feb; 50(1):94-99. PubMed ID: 36789646
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.
Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161
[TBL] [Abstract][Full Text] [Related]
10. Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo.
de Bock CE; Garg MB; Scott N; Sakoff JA; Scorgie FE; Ackland SP; Lincz LF
Pharmacogenomics J; 2011 Aug; 11(4):307-14. PubMed ID: 20531375
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase enhancer region: Novel allele in Indians.
Dhawan D; Padh H
Ann Hum Biol; 2017 Feb; 44(1):87-90. PubMed ID: 27009482
[TBL] [Abstract][Full Text] [Related]
12. Gender-dependent association of
Ioannou C; Ragia G; Balgkouranidou I; Xenidis N; Amarantidis K; Koukaki T; Biziota E; Kakolyris S; Manolopoulos VG
Pharmacogenomics; 2021 Jul; 22(11):669-680. PubMed ID: 34100299
[No Abstract] [Full Text] [Related]
13. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
[TBL] [Abstract][Full Text] [Related]
14. Analysis of polymorphisms and haplotype structure of the human thymidylate synthase genetic region: a tool for pharmacogenetic studies.
Ghosh S; Hossain MZ; Borges M; Goggins MG; Ingersoll RG; Eshleman JR; Klein AP; Kern SE
PLoS One; 2012; 7(4):e34426. PubMed ID: 22496803
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatography.
Ezzeldin H; Hoffmayer C; Soong R; Johnson MR; Lee A; Heslin M; Diasio R
Anal Biochem; 2004 Nov; 334(2):276-83. PubMed ID: 15494134
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.
Meulendijks D; Jacobs BA; Aliev A; Pluim D; van Werkhoven E; Deenen MJ; Beijnen JH; Cats A; Schellens JH
Int J Cancer; 2016 Jan; 138(1):245-53. PubMed ID: 26189437
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in Korean patients with gastric cancer].
Lee J; Jeong CK; Hong SP; Chong SY; Oh D; Hwang SG; Ahn DH; Kim S; Han JH; Kim NK
Korean J Gastroenterol; 2005 Jul; 46(1):32-8. PubMed ID: 16030402
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele.
Lincz LF; Scorgie FE; Garg MB; Ackland SP
Int J Cancer; 2007 May; 120(9):1930-4. PubMed ID: 17278107
[TBL] [Abstract][Full Text] [Related]
20. First Case of Foot Drop Associated with Capecitabine in a Patient with Thymidylate Synthase Polymorphism.
Wilks AB; Saif MW
Cureus; 2017 Jan; 9(1):e995. PubMed ID: 28280649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
